Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Express Scripts
Merck
McKinsey
Johnson and Johnson

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: FINGOLIMOD HYDROCHLORIDE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

FINGOLIMOD HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis GILENYA fingolimod hydrochloride CAPSULE;ORAL 022527 NDA Novartis Pharmaceuticals Corporation 0078-0607-15 30 CAPSULE in 1 BOTTLE (0078-0607-15)
Novartis GILENYA fingolimod hydrochloride CAPSULE;ORAL 022527 NDA Novartis Pharmaceuticals Corporation 0078-0607-89 7 CAPSULE in 1 CARTON (0078-0607-89)
Novartis GILENYA fingolimod hydrochloride CAPSULE;ORAL 022527 NDA Novartis Pharmaceuticals Corporation 0078-0965-89 7 CAPSULE in 1 CARTON (0078-0965-89)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Dow
Merck
McKinsey